In recent decades, the emphasis of biomarker research has centered around blood-based markers. However, blood biomarkers alone cannot capture the full spectrum of clinically relevant indicators.
From the Stone Clinic, Massachusetts General Hospital, Boston. Select the format you want to export the citation of this publication.
SGLT2 Inhibitors Linked to Lower Risk of Kidney Stones in Patients With Type 2 Diabetes: Study Shows
Thailand: Use of sodium-glucose co-transporter-2 inhibitors (SGLT2is) may help reduce the risk of kidney stone formation in ...
For permission requests, please contact NEJM Reprints at [email protected] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback